Study to Assess Efficacy and Safety of Bulevirtide in Combination With Pegylated Interferon Alfa-2a in Participants With Chronic Hepatitis Delta (CHD)

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2019
The primary objective of this study is to evaluate the efficacy of bulevirtide combination with pegylated interferon in participants with chronic hepatitis delta (CHD).
Epistemonikos ID: c4015ee1543a18e477496a8ba3911b4706bb2ad4
First added on: May 22, 2024